SOPHiA GENETICS Raises 2025 Revenue Guidance After 23% Q3 Growth
SOPHiA GENETICS reported third-quarter 2025 revenue of $19.5 million, a 23% increase year-over-year, and raised its full-year revenue guidance to between $75 million and $77 million. The company highlighted strong adoption of its SOPHiA DDM platform and expanded partnerships in precision medicine.